Report error Found 45 Enz. Inhib. hit(s) with all data for entry = 50044668
Affinity DataKi: 10nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 11nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 13nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 14nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 15nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 18nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 19nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 20nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 22nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 22nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 24nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 25nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 25nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 31nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 32nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 34nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 34nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 37nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 38nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 40nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 58nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 59nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 60nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 74nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 79nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 81nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 86nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 87nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 90nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 90nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 93nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 109nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 130nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 156nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 160nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 161nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 170nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 173nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 177nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 207nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 219nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 237nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 238nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 247nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair
Affinity DataKi: 248nMAssay Description:Inhibition of purified His6-tagged recombinant human HPPD assessed as inhibition of maleylacetoacetate formation after 30 mins by UV/visible spectrop...More data for this Ligand-Target Pair